Described herein are pharmaceutical packaging programs which protect against oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate medication, these types of devices which includes a syringe having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with incredibly reduced p